Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults
Authors not listed
NMD Pharma A/S · 2021
Abstract
Sarcopenia is a condition characterised by age-related loss of muscle mass and function. Factors affecting the strength of muscle contraction independent of mass, such as neuromuscular junction (NMJ) transmission, are increasingly suspected as important contributors to the development of age-related physical disability. The group of investigators leading the current study, have recently demonstrated NMJ transmission deficits in aged mice, but whether this translates in older human individuals is not known
The primary aim is to assess whether clinically meaningfull muscle weakness is associated with NMJ transmission deficits in older human individuals with clinically meaningfull muscle weakness.
The secondary aim is to assess whether NMJ transmission deficits correlate with different measures of functional capacity to inform future trials of the most appropriate choice of tests.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Anonymous. (2021). Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults. <em>NMD Pharma A/S</em>. https://clinicaltrials.gov/study/NCT04904926
Vancouver
Anonymous. Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults. NMD Pharma A/S. 2021.
BibTeX
@misc{anon2021Invest,
title = {Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults},
author = {Anonymous},
journal = {NMD Pharma A/S},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2010
Citation only
Sarcopenia – Age-Related Muscle Wasting and Weakness
GeroScience 2025
Open access · OA
HDAC11 deficiency regulates age-related muscle decline and sarcopenia
Springer eBooks 2007
Citation only
Slowing down age-related muscle loss and sarcopenia
Redox Biology 2018
Open access · CC-BY
Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) 2011
Preprint
Sarcopenia - age-related muscle wasting and weakness : mechanisms and treatments
Scientific Reports 2016
Open access · CC-BY